Parkman Healthcare Partners LLC Procept Bio Robotics Corp Transaction History

Parkman Healthcare Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$26.64 - $39.74 $1.2 Million - $1.79 Million	-45,066 Reduced 40.12%	67,252 $1.91 Million
Q4 2022 Feb 13, 2023	BUY	$38.78 - $46.78 $431,117 - $520,053	11,117 Added 10.99%	112,318 $4.67 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $207,060 - $339,405	6,701 Added 7.09%	101,201 $4.2 Million
Q2 2022 Aug 12, 2022	BUY	$29.23 - $44.45 $2.76 Million - $4.2 Million	94,500 New	94,500 $3.09 Million

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.17B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.